Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial

BACKGROUND: Vitamin D receptor activators reduce albuminuria, and may improve survival in chronic kidney disease (CKD). Animal studies suggest that these pleiotropic effects of vitamin D may be mediated by suppression of renin. However, randomized trials in humans have yet to establish this relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Thomas, Mose, Frank H, Bech, Jesper N, Pedersen, Erling B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729723/
https://www.ncbi.nlm.nih.gov/pubmed/23889806
http://dx.doi.org/10.1186/1471-2369-14-163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729723/
https://www.ncbi.nlm.nih.gov/pubmed/23889806
http://dx.doi.org/10.1186/1471-2369-14-163

Ejemplares similares